Copy of Our Services

Our Services
Trusted, Transparent, Tailored 
Strategic Consulting for Drug Development
Partner with us for comprehensive strategic guidance throughout your drug development journey. We provide hands-on strategic consulting that transforms complex challenges into clear, actionable strategies.

Product development and portfolio optimization
Regulatory strategy insights
Competitive landscape analysis
QD Drug Development Platform Access
Unlock the power of our proprietary Quantify Decisions (QD) drug development platform —an AI-powered platform that revolutionizes how you build optimized Product Development Plans and Target Product Profiles.

Utilize FDA, EMA, ​Health Canada regulatory information as well as ClinicalTrials.gov​ and CTIS data for comprehensive trial insights
Competitor pipelines, efficacy outcomes and safety insights
Product development gantt charts and target product profiles quantified by totality of evidence
QD Reports for Portfolio Overviews
Need focused insights on a specific development question? Our targeted reports leverage the QD drug development platform to deliver deep analysis relevant for your portfolio and ready for your upcoming decision-making.

Indication- and MoA-specific assessments
Quantifying your Target-Product Profile up against competitor pipelines
Critical path analysis to optimize your product development plan and invest where it matters
How We Work
Seek - Select - Secure
Our comprehensive approach integrates commercial, regulatory, and clinical considerations into every decision, ensuring your drug development program is positioned for success from day one. We don't just provide advice—we quantify the impact of every strategic choice. We commit to provide all relevant data for every decision we help you make. We do this in three simple steps. 
1
Seek
We begin by understanding your strategic objectives and  drug development challenges to pinpoint the key questions and identify unique opportunities.
2
Select
We select and analyze evidence— from clinical operations data, regulatory insights to competitive intelligence — using our proprietary QD drug development platform.
3
Secure 
We transform complex data into clear, quantified recommendations that optimize speed, regulatory success, and commercial outcomes thereby securing your optimal decision-making.
Our Success Stories
Optimizing Drug Development Strategies
From LPLV to Submission
Challenge: Accelerating the complex transition from Last Patient Last Visit (LPLV) to a complete and compliant regulatory submission, while ensuring data integrity, interpretation and managing multiple stakeholders.
Outcome: Successfully streamlined process from LPLV to Submission cutting it down from 6 months to 12 days.
Regulatory Bridging Strategy
Challenge: Navigating different regulatory requirements across key global markets to secure broadest possible label for innovative therapy without requiring redundant clinical trials.
Outcome: Multiple examples of re-using data across trials to get new dose regimens approved, avoiding new clinical trials and supporting new patient populations.
QD Report to Differentiate
Challenge: Clearly articulating the unique value proposition of a new drug in a competitive therapeutic area to key opinion leaders and payers, ensuring strong market uptake.
Outcome: Quantified Decision (QD) reports utilized to highlight superior efficacy and safety profiles and addressing unmet patient needs.
Pharm·ology ApS
contact@pharmology.dk
CVR: 45557898

Pharm·ology - The Science of Drug Development

126,097
Industry-Sponsored Clinical Trials
13+ million
Outcome & Adverse Event Measures
28,302
Regulatory FDA & EMA Approvals
                        Pharm·ology
The Science of Drug Development 